Page last updated: 2024-10-21

hydroxyindoleacetic acid and Brain Injury, Chronic

hydroxyindoleacetic acid has been researched along with Brain Injury, Chronic in 1 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Brain Injury, Chronic: Conditions characterized by persistent brain damage or dysfunction as sequelae of cranial trauma. This disorder may result from DIFFUSE AXONAL INJURY; INTRACRANIAL HEMORRHAGES; BRAIN EDEMA; and other conditions. Clinical features may include DEMENTIA; focal neurologic deficits; PERSISTENT VEGETATIVE STATE; AKINETIC MUTISM; or COMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christofides, J1
Bridel, M1
Egerton, M1
Mackay, GM1
Forrest, CM1
Stoy, N1
Darlington, LG1
Stone, TW1

Other Studies

1 other study available for hydroxyindoleacetic acid and Brain Injury, Chronic

ArticleYear
Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.
    Journal of neurochemistry, 2006, Volume: 97, Issue:4

    Topics: Administration, Oral; Aged; Biomarkers; Brain; Brain Injury, Chronic; Down-Regulation; Female; Food,

2006